Pay in 4 interest-free payments of $5.53 Learn more
Ships within 48 hours · Estimated delivery Sep 29 - Oct 4
EX-4 or AICAR treatment dramatically increased insulin secretion and was further increased by co-treatment of them (Figure 2E)
The total on your checkout screen is what you're actually agreeing to, and that's what you should confirm before completing the transaction
A: It is the first triple agonist (GLP-1 + GIP + Glucagon) studied in Phase 3 trials
GLP-1 receptor activation suppresses appetite, slows gastric emptying, and enhances insulin secretion in a glucose-dependent manner
US$ 20.62
US$ 26.38
